key: cord-0034252-8tnilcq0
authors: nan
title: DIALYSIS. EPIDEMIOLOGY, OUTCOME RESEARCH, HEALTH SERVICES 1
date: 2014-05-03
journal: Nephrol Dial Transplant
DOI: 10.1093/ndt/gfu158
sha: d82bf7e7b4b855badd9bd10fdca148d775d54155
doc_id: 34252
cord_uid: 8tnilcq0

nan

Introduction and Aims: Epidemiologic data have demonstrated elevated cancer risk in hemodialysis (HD) patients. The aim of the present study was to evaluate the demographic, clinical and biochemical determinants of cancer development in HD patients. Methods: The MONitoring Dialysis Outcomes (MONDO) consortium consists of HD databases from Renal Research Institute (RRI) clinics in the US, Fresenius Medical Care (FMC) clinics in Europe, Asia Pacific (AP), Latin America (LA), KfH clinics in Germany, Imperial College, London, UK, Hadassah Medical Center, Jerusalem, Israel, and University of Maastricht, The Netherlands. We extracted data for only those patients who survived at least 12 months after the start of HD. Ninety-four HD patients with pre-existing cancer were excluded from the analysis. We used available variables to construct regression models to predict cancer development during 2 year follow-up. Candidate predictors included demographic characteristics (age, sex), comorbidities (diabetes, hypertension, cardiovascular disease (CVD), coronary artery disease (CAD), smoking), body mass index (BMI), dialysis parameters (eKtV, urea reduction ratio (URR), vascular access, erythropoietin dosage, intra-dialytic weight gain (IDWG), normalized protein catabolic ratio (nPCR)) and laboratory tests (albumin, hemoglobin (Hgb), sodium, potassium, calcium, phosphorus, ferritin, serum creatinine (sCR), white blood cell count, platelets, and total cholesterol). Continuous variables were converted into categorical ones based on optimal clinical cut off points in a preprocessing step. Categorical variables were pre-screened using Chi-square test (P < 0.1). Stepwise forward method was used for variable selection in the multiple logistic regression. Results: 22024 HD patients were studied (Eastern Europe: 4830, Western Europe: 367, Northern Europe: 1937 , Southern Europe: 7189, Western Asia: 2115 . The mean (SD) age was 63.2±15.0 years, 58.7% were males. The overall incidence of cancer was 0.84% (185 cases), and 0.3% (57 cases) of HD patients had cancer-related death. The incidence of cancer was highest in Eastern Europe (1.6%, 78 cases) and lowest in Western (0.3%, 1 case) and Northern Europe (0.3%, 5 cases). Men older than 75 years had trend towards higher cancer incidence as compared to older female (1.2% vs 0.7%; P =0.07). The multivariable logistic regression model to predict two-year risk of cancer retained the following variables: age, BMI, ferritin, albumin, Hgb, eKtV, vascular access, CAD, diabetes, and IDWG. The model, significant predictors, and unstandardized β coefficients with 95% CI are presented in Table 1 . Conclusions: Our study identifies clinical relevant risk factors to predict cancer in HD patients. This risk assessment model could help clinicians to stratify patients for cancer screening, surveillance, prevention and early therapeutic intervention. Further studies are needed to validate our model in an externally derived cohort to evaluate its generalizability.

Introduction and Aims: Assisted peritoneal dialysis (aPD) is now more available as an alternative to hospital haemodialysis (HD) for frail older patients but the lack of outcome data comparing HD with aPD has limited its use. FEPOD part 1 reported no significant difference in the primary outcomes of quality of life and physical functioning, except for higher prevalence of possible depression in the aPD group. This report describes the secondary outcomes for the study group. SECONDARY OUTCOMES: Hospitalisation, falls, symptom burden, cognition and patient satisfaction. Methods: aPD patients and HD patients were recruited from 11 centres. The HD patients were matched to recruited aPD participants by age, sex, diabetes status, time on dialysis, ethnicity and Index of Deprivation. The MiniMental State Examination (MMSE) and the Trail Making Form B were used to assess global cognitive function and executive function respectively. Falls and symptom burden were assessed using a falls questionnaire and the Palliative Outcome Symptom scale (renal) respectively. Patient satisfaction was measured using the Renal Treatment Satisfaction Questionnaire Results: 106 patients (52 HD; 54 aPD) were recruited. 35 % of the study group had at least one hospital admission in the preceding three months. 42% of all admissions were dialysis related. 28% of the study group had at least one fall in the preceding three months.83.3% of them occurred at home, with the HD group sustaining more fractures than the aPD group (26.7% HD vs. 6.7% aPD, p=0.329). Lethargy, pain and poor mobility were predominant in the study group. The median number of reported symptoms were 9 (IQR 7 -11) in the HD group and 10 (IQR 7.75 to 13) in the aPD group. 42.3% of HD patients reported no improvement in symptoms since starting dialysis, as against 25.9% of the aPD group. 10.5% of the study group had abnormal MMSE scores (<24). There was no statistical difference in MMSE scores between HD patients and aPD patients [mean , 28 (aPD), p=0.120]. In contrast, 36.8% had executive dysfunction (trail making B test time > 300 seconds). Executive dysfunction was more prevalent in the aPD group [54.2% aPD vs. 27.7% HD, (p = 0.089)]. Despite the above outcomes, 91.5% of the study group would recommend their therapy to others (mean total renal treatment satisfaction scores -49.6 HD vs. 50.3 aPD, p=0.722).

Conclusions: There is a high prevalence of falls, symptom burden, executive dysfunction and hospitalisation in frail elderly dialysis patients, irrespective of dialysis modality. This should be considered during discussions about renal replacement modalities (including non-dialytic care). FEPOD part 2, the longitudinal phase of the study, will provide information on the influence of dialysis modality on the trajectory of these outcomes.

Introduction and Aims: Mortality and morbidity during first 90 days on HD are indicators of pre-dialysis care and patient status at HD initiation. Here we explore the association between early predictors, i.e. factors captured in the first 30 days on HD, and hospitalization in the first year on HD in a large international sample of incident HD patients. Results: Among 501 patients who underwent adiponectin measurement (mean ± SD 26.9 ± 17.6 mcg/ml; range 5.3-100.0 mcg/ml), the mean ± SD age of the cohort was 55.2 ± 14.9 years, of whom 44% were female, 40% were African-American, and 47% had diabetes. Compared with the lowest adiponectin tertile, the highest adiponectin tertile was associated with increased all-cause mortality risk in adjusted, case-mix, and case-mix + laboratory adjusted models ( Table 1 ). The second adiponectin tertile was associated with numerically greater risk, but estimates were not statistically significant.

In sensitivity analyses that examined adiponectin as a continuous variable, we observed that incrementally higher adiponectin level was associated with increased death risk (Table 2; Figure 2 ). Conclusions: Higher circulating adiponectin levels in hemodialysis patients are paradoxically associated with higher all-cause mortality. Future studies are needed to confirm findings and to elucidate mechanistic pathways.

Introduction and Aims: Infectious complications among dialysis patients are a major cause of morbidity and non-cardiovascular mortality. Dialysis modality has been hypothesized to be a potential immunomodulatory factor. The objective of this study was to investigate the association between dialysis modality and the risk for overall and specific infectious complications and to distinguish the risk for dialysis technique and non-dialysis technique related infections. Methods: Our study was conducted in The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) cohort that consists of 2052 incident dialysis patients. From this cohort, data on infectious complications of patients from 2 university teaching hospitals and 3 regional hospitals were retrospectively collected using strictly pre-specified criteria. Information about the incidence and nature of infections was collected from dialysis start until death, modality switch, withdrawal from the study, transfer to another dialysis center, kidney transplantation, or at the end of study follow up. Age-standardized incidence rates for infections were calculated. Poisson regression was used to calculate incidence rate ratios that were adjusted for age, sex, diabetes, BMI, Kahn co-morbidity score, primary kidney disease, ethnicity, malignancy, chronic pulmonary disease and educational level. Results: In total, 452 patients with complete medical records were included, of whom 285 started with haemodialysis (HD) and 167 with peritoneal dialysis (PD). The median follow-up time on the first dialysis modality was similar on HD and PD: 1.8 and 2.0 years. During the first 6 months, the age-standardized infection incidence rate was significantly higher on HD: Introduction and Aims: Increasing evidence are showing that high dose haemodialysis (more frequent and/or longer duration hemodialysis (HD)) can improve clinical and humanistic outcomes. We compared the expected health gains (measured as life-years -LYs -and quality-adjusted life-years -QALYs -gained) if high dose HD and other home dialysis modalities were used in a greater proportion of the dialysis patients than currently observed. Methods: A Markov model was built for the UK environment. Various combinations of high dose HD (in-center or at home) and peritoneal dialysis (PD) were compared to the current usage (i.e., 83% conventional in-center HD; 14% PD; 3% conventional home HD; 0% high dose home HD). Inputs included: incidence, prevalence, transplant rates (UK renal registry); complications, utilities and transition between modalities (medical literature); survival (PD & conventional HD: ERA-EDTA registry; high dose HD: medical literature). The model was run for 5 years with the prevalent dialysis population and an incident cohort entering the model each year in years 2-5. Results: Over the 5-year period, the scenario where all patients received in-center conventional HD generated a loss of 678 LYs (-0.6%) and 838 QALYs (-1.2%) for the cohort. Treating all patients with high dose HD in-center or at home, although likely unrealistic, increased the cohort's LYs by 4.5-4.8% and QALYs by 10.7-26.7%. All other (less extreme) scenarios led to increasing LY and QALY gains with increasing usage of home modalities. A more realistic scenario where 10% of patients received high dose HD at home and PD usage was back to years 2005-2008 levels, i.e., 25%, generated 963 LY (+0.8%) and 1827 QALY (+2.6%) gains.

Conclusions: This analysis shows that high dose HD, especially when performed at home has the potential to significantly increase the health gains of the dialysis population. This analysis also shows that treating increasing the in-center HD patient population results in health losses.

Til Leimbach 1 , Joachim Kron 1 , Jutta Czerny 1 , Birgit Urbach 1 , Sabine Aign 1 and Susanne Kron 2 1 KfH-Nierenzentrum Berlin-Köpenick, Berlin, Germany, 2 Charite Universitätsmedizin Berlin, Berlin, Germany Introduction and Aims: In Germany every fifth incident dialysis patient currently is 80 years of age or older. The question arising is no longer, if to treat these patients but how. Methods: Single centre data of all dialysis patients aged over 80 years were analyzed with regard to survival, social circumstances, vascular access and predialysis nephrology care. Results: Between 2001 and 2012 76 patients over 80 years of age started chronic ambulatory haemodialysis treatment. One-year survival was 87 %, 3-year survival 52 %, 5-year survival 27 % and 10-year survival 9 %, respectively. Patients (n = 55) with more than 3 month of nephrological care prior to dialysis (3 to 161 month, median 31 month) survived significantly longer then patients (n=21) having had less than 3 month contact to nephrologists. On 31th December 2012 there were 38 patients (18 female and 20 male) aged ≥ 80 years (median age 84 years, 80 -95 years) in the chronic haemodialysis program, thus accounting for 19% of all dialysis patients of this centre. The median duration on dialysis was 50 months (1 -155 months). All patients had two or more comorbidities.33 patients (87%) lived at home (9 patients single, 24 with spouse), 2 patients lived with relatives and 3 patients were nursing home residents. Concerning vascular access 31 patients (82%) had a native av-fistula, 3 (8%) a graft and 4 patients (10%) a catheter. The respective vascular access had been used for 43 month (1 -155 month) . 10 access complications occurred in 8 patients, in 4 cases a new vascular access had to be established (3 grafts, 1 catheter). Consequentially, one access was lost in 39 patient years on dialysis. Compared to all in-centre patients (one loss in 37 patient years) the elderly suffered less access failures overall. Prior to starting dialysis 30 patients (79%) had been in long-term nephrological care (3 -161 month, median 45 month) and 3 patients were referred late (< 3 month prior first dialysis). In 5 patients dialysis was started following emergency referral to hospital. 31 patients (82%) started the first dialysis treatment with a functioning shunt access, 4 (10%) with a permanent catheter and 3 (8%) with a temporary catheter. Conclusions: The life expectancy and social status of patients starting dialysis aged 80 years or older were nearly comparable to the general population of the same age. Long-term predialysis nephrology care is of most importance for successful dialysis treatment in the elderly especially in Octogenarians and Nonagenarians. Early establishment of a functioning vascular access and careful scheduling of first dialysis treatment reduce complications and increase both survival and quality of live. The use of catheters can be avoided in almost all patients over 80 years.

Introduction and Aims: Haemodialysis (HD) is the most common dialysis modality for frail older patients although many tolerate this poorly and have transport problems. Assisted peritoneal dialysis (aPD) is increasingly available to enable home treatment.

There is no data about patient outcomes on aPD compared to HD. This study has been designed in 2 parts. Part 1 is a cross-sectional study obtaining a snapshot view of patient well-being on aPD compared to HD. Part 2 is a prospective longitudinal study determining patient outcomes over 2 years. This report focuses on the results of Part 1. PRIMARY OUTCOME: Comparison of quality of life and physical function of prevalent frail older patients on aPD and HD Methods: aPD patients (defined as requiring assistance to perform PD by paid or unpaid carer) and HD patients (requiring hospital transport) were recruited from 11 centres. All were ≥60 years, on dialysis for ≥3 months and free from hospitalisation for 30 days. The HD eligible patients were matched to recruited aPD participants by age (±3 years), sex, diabetes status, time on dialysis (± 2 years), ethnicity and Index of Deprivation. Quality of life assessments were made using Hospital Anxiety and Depression Scale (HADS), SF-12, Palliative Outcome Symptom Scale and Illness Intrusiveness Rating Scale. Physical function was assessed by Barthel score (measure of aids to daily living) and Timed Up and Go. Results: 54 aPD and 52 matched HD patients were studied. Mean age was 74.1 ± 7.5 and 72.7 ± 7.8 years respectively; presence of frailty was similar between both modalities (57.4% on aPD and in 42.3% on HD). Multivariate analyses with p-values derived from a generalised linear model showed that frailty score was the most influential variable in relation to outcomes: SF 12 physical p=0.002; SF 12 mental p=0.03; Barthel p<0.0001; Timed Up and Go p<0.0001. Dialysis modality was the most influential variable in determining the total HADS score (mean aPD 12.6, HD 9.5, p=0.0472) and symptom score (median aPD 17, HD 13.5, p=0.023). Using a propensity score derived from age, gender, frailty and comorbidity scores to compare pairs of participants on aPD and HD, showed that the significantly higher HADS score on aPD (P=0.03) remained but not the symptom score (P=0.37). Probable depression (HADS >8) was also more common in the aPD group ( p=0.0442). Conclusions: Degree of frailty is the major determinant of quality of life and physical function. Dialysis modality has a minor role with probably slightly more depression in the aPD group but this needs confirming in the larger longitudinal study. Both aPD and HD should therefore be discussed as potential modalities leaving choice to individual patients.

Ikuto Masakane 1 and E-HOPED Study Group 1 1 Yabuki Hospital, Yamagata, Japan

Introduction and Aims: Several recent reports warned that high efficient hemodialysis with polysulfone (PS) membrane occasionally led to the deterioration of nutritional status in elder patients. Ethylene vinyl alcohol (EVAL) membrane has high biocompatibility and a broad solute removal property but efficacy of uremic solute is less than that of PS. In the prior studies, EVAL membrane improved the deteriolated nutritional status caused by PS membrane. The E-HOPOED-Study Group was established in 2010 to determine the best dialyzer choice for elder dialysis patients with early dialysis stage.

Methods: The E-HOPED-Study is a open-label, dynamically allocated, central registrated, randomized control trial being performed in 325 dialysis facilities in Japan. The patients who accept the enrollment to the study will be randomly divided into the next two groups; Group A, treated by EVAL membrane; Group B, treated by several high flux membrane such as PS. The entry criteria of the patients are the age more than 70 years old, the dialysis vintage less than 180 days. The patient registration has just finished on Dec. 31st 2013. Finally 795 patients; 398 patients in Group A and 397 in Group B, were enrolled into the study. The 5 year-survival, changes in the nutritional status, occurrence of complications and others are the end points. Dimographic data of all 795 patients and an interim analysis for 536 patients whose clinical data could be followed longer than 12 months were included into this study. Nephrologists often face difficult treatment recommendations for elderly end stage kidney disease (ESKD) patients with respect to dialysis versus supportive (non-dialysis) care, given uncertainty around survival benefit and considerable treatment burden. We aimed to define nephrologists' preferences for dialysis recommendation in elderly patients and to assess trade-offs between patient characteristics. Methods: We conducted a discrete choice experiment (DCE) of Australasian nephrologists. The DCE design was informed by a ranking exercise of characteristics derived from the literature and a pilot DCE of 30 nephrologists. We assessed the influence of patient characteristics (age, gender, cognition, comorbid burden, life expectancy, current quality of life (QOL), expected QOL change with dialysis, social support, patient and family inclination for dialysis) on nephrologists' preferences for dialysis recommendation. The online DCE consisted of 12 scenarios, each with two elderly patients described in terms of the 10 characteristics. Nephrologists were asked which of the hypothetical patients, they would prefer to recommend dialysis to or whether they would recommend dialysis to neither patient. Respondent sociodemographic characteristics were also collected. Analysis used a random parameters logit model with results as the odds of recommending dialysis over no dialysis. Marginal rates of substitution (trade-offs) between QOL and survival were calculated.

Results: 159 of 415 (38%) nephrologists participated in the DCE. Roughly one third (34%) were aged between 40-49years, 62% were male and 69% were Caucasian. Nephrologists chose "neither patient" for 57% of the scenarios. All patient characteristics other than gender significantly affected the likelihood of dialysis recommendation. Nephrologists were more likely to recommend dialysis to patients with preserved cognition, lower comorbid burden, increased life expectancy and high current QOL. Patient and family inclination for dialysis also favoured dialysis recommendation. Nephrologists were less likely to recommend dialysis with each extra year of age and when dialysis was expected to decrease QOL. Nephrologists aged >65 were almost 12 times more likely to recommend dialysis compared with younger counterparts. Nephrologists were willing to forgo 12 months of patient dialysis survival in order to avoid a substantial decrease in patient QOL with dialysis initiation. Conclusions: Many patient characteristics were considered by nephrologists when recommending dialysis. Nephrologists were much more likely to recommend dialysis to those with normal cognition and those inclined for dialysis, and avoided recommending dialysis when initiation was expected to considerably reduce QOL. These findings highlight the need to systematically and longitudinally evaluate cognition and QOL when contemplating dialysis decisions in elderly patients. Introduction and Aims: Hypertension is very poorly controlled in patients on haemodialysis (HD) and hypertension is predictor of cardiovascular mortality in HD patients. Patients with thrice-weekly HD have higher predialysis weights (PWG) and ultrafiltration rates (UF) on the first compared with subsequent HD of the week. We hypothesized that these variations in PWG and UF are associated with a systematic difference in blood pressure. The aim of this study was to examine mean arterial pressure (MAP) and pulse pressure (PP) in HD patients and to assess the relationships between these parameters and PWG and UF. Methods: In this study 402 patients (aged 68.3±13.8 years) on maintained HD (4.73 ±5.17 years) were included (232 males, 170 females) in Dalmatian centres in Dalmatia county in Southern Croatia. Blood pressure measurement was undertaken at the first HD session on the beginning of the observed week. For every single observed HD mean arterial pressure (MAP) calculated as ((systolic + 2 diastolic blood pressure)/3) (mmHg) and pulse pressure (PP) computed as (systolic -diastolic blood pressure) (mmHg) predialysis and postdialysis were measured. Therefore, PWG and UF rate were calculated as average value during 4 weeks (12 HD treatments) prior tis study.

Results: These results showed influence of PWG and UF on blood pressure in HD patients. There were statistically significant correlation between average PWG and post HD MAP value (r = -0.131, p=0.004) indicating that higher PWG lead to hemodynamic instability and lower blood pressure in HD patients after HD treatment. Also, higher UF rate was significantly correlated with lower MAP and PP before and after HD treatment as shown in Table 1 .

Conclusions: Restriction in PWG and controling UF rate during HD session is important becouse these two parameters might influence blood pressure parameters in HD patients. It is well known that poor blood pressure control in HD patients leads to increased cardiovascular morbidity and mortality, so further reserch should evaluete improvement of blood pressure parameters and hemodianamic stability in these patients by PWG restriction and lower UF rate.

Personal Health Records (EPR) designed to educate patients as well as enable them to participate in the monitoring and management of their renal disease in UK. It may therefore have a role in equipping patients to make an informed choice of dialysis modality when beginning RRT, one of the key standards proposed in The National

Service Framework (NSF) for Renal Services. Most patients offered an informed choice choose a home-based modality, and pre-dialysis education has been reported to strengthen this trend. On this background we hypothesised that patients that utilised RPV are better informed about choice of modality and more likely to choose home-based modalities for first RRT provision. The aim was to investigate first dialysis modality in RPV users and non-users. Methods: The RPV user database extant on January 25th 2012 was linked by patient CHI / NHS number with the UK renal registry and anonymised data extracted for analysis. The extract was restricted to adult patients and included patient demography, deprivation indices, ethnicity, UKRR timeline data and referral time (time between first referral to nephrologist and date of starting RRT), date of beginning RRT, date of first logon to RPV, and measures of patient utilisation of RPV derived from log file analysis as reported elsewhere. Patients with a referral time of <90 days were excluded. RPV users were grouped by the interval between their first logon to RPV and their date of starting RRT, and comparison made between patients that had been users of RPV for at least 90 days before beginning RRT (longer term users) and users that began their use of RPV after starting RRT (late users). Logistic regression and Chi-squared tests were performed using SAS v 9.3. Results: Longer term RPV users were more likely than late users to begin RRT on a home based modalities (Home Haemodialysis or Peritoneal dialysis) than hospital haemodialysis (571/1345 and 543/1453 respectively, p = 0.006). The association was stronger for longer term users that logged into RPV more persistently suggesting the effect was related to the patients themselves rather than any selection by the centre of patients offered RPV (481/1068, p = 0.0001). By 90 days after starting RRT the difference in prevalence of home-based modality provision to longer term and late RPV users had waned but was still significant ( p = 0.037, 0.032 for persistent RPV users). The results were not just a proxy for a longer referral period (so more time to initiate RPV) as a similar pattern was found when patients with referral time <6 months of < 1 year were excluded. Controlling for age, sex, deprivation and ethnicity, longer term persistent RPV users were 31% (10-57%, 95% CI) more likely to begin RRT on a home-based modality than late users, and almost three times more likely than the overall RRT population. Longer term RPV users were more likely to begin RRT with a live transplant compared to late users (217/342 and 150/274 respectively, p = 0.029), even when controlling for age, sex and deprivation, and similarly, this association had weakened by 90 days after starting RRT ( p = 0.22).

The results demonstrate an association between using RPV and beginning RRT on a home-based modality or with a live donor transplant. The greater strength of the association for users that make greater use of RPV is consistent with our hypothesis that RPV is contributing to patient's discovery around RRT modality choice. Introduction and Aims: Approximately 53,000 patients received renal replacement therapy (RRT) for end-stage renal disease (ESRD) in the UK in 2011, resulting in a substantial economic burden. Evidence suggests that high dose haemodialysis (more frequent and/or longer duration hemodialysis (HD)) may be associated with better health outcomes and can be cost savings in the UK (if conducted at home with the current tariff ) versus conventional in-centre HD (ICHD). However, the current weekly tariff for home dialysis in the UK is not reflecting the increased production costs associated with an increased number of dialysis sessions per week. We investigated the financial impact of increasing the proportion of ESRD patients on home-based dialysis modalities, especially high dose HD at home with increased tariff, from the UK payer perspective.

Methods: A Markov model was constructed reflecting the natural history of dialysis patients; based on this, a budget impact analysis was performed over a 5-year time horizon from the perspective of the English National Health Service (NHS Introduction and Aims: Low free triiodothyronine (fT3), largely an epiphenomenon of inflammation and protein-energy wasting, is a strong predictor of mortality in end-stage kidney disease (ESKD). Fibrinogen is a marker of inflammation and a key molecule transducing the effect of inflammation on the coagulation cascade. We hypothesized that the risk associated with low fT3 in ESKD can be modified by fibrinogen levels in these patients. Methods: We tested this hypothesis in a cohort of 854 dialysis patients with a 2.7 years follow-up. Results: During follow-up, 261 patients died, 138 of whom of CV causes. The risk of low fT3 levels for all-cause and CV death was strongly modified by fibrinogen levels. In fully adjusted Cox models (including age, gender, smoking, diabetes, cholesterol, systolic BP, CV comorbidities, Hb, phosphate and dialysis vintage), the hazard ratios (HR) associated to low fT3 levels for the study outcomes were lowest in patients in the Introduction and Aims: The patients' involvement in the selection of dialysis method allows them to choose the most fitted therapy to their psycho-socio-economic status and could influence short and even long-term outcome. However, this was not investigated in Romanian patients.

Methods: Questionnaires were sent by the Romanian Renal Registry to patients who started dialysis in 2012 in 42 dialysis units from public hospitals, large private dialysis networks and independently run private dialysis units, all-around the country. The self-reported questionnaires addressed patients' perception of overall satisfaction with the treatment modality (2 items), of the perceived personal involvement in the decision-making process of choosing dialysis method (5 items), and possible ways to improve the process from patients' perspective (3 items).

Results: Responses were received from 680 patients (average age 58 years, 56% males, 89% on hemodialysis, 7% of the dialysis patients in the country). A positive self-perception of health quality was significantly related to the psychological acceptance of dialysis therapy (which was dependent on information received), and to the emotional health. In 73% of cases the choice of the method was made collaboratively by patient and physician. Although only 17% of respondents integrally assumed the decision, those patients had a better overall satisfaction with the dialysis method(r=0.08; p=0.05), while in patients in whom the choice of the method was made exclusively by physician, a trend to a lower quality of health was reported (r=-0.05; p>0.05). The responders' option for a certain treatment modality was guided by the perceived safety (55%), by their ability to manage the method (50%), and was influenced by the quality of information received about the method (37%). As the self-perceived quality of health was not related to either the initial or the actual method of dialysis, and the actual method was strongly correlated to the initial method (r=0.78; p=0.01), the probability to change the initial method seems to be low. In patients' opinion, the choice of dialysis method could be improved by educational programs (62%) and psychological assistance (57%).

Conclusions: The patients' perception of health quality is related to the choice of the initial dialysis method. However, in a too low proportion the patients have enough information to make a conscientious choice and most of them feel that programs of medical education and psychological assistance are needed in the pre-dialysis period. Introduction and Aims: Patients with end stage renal disease (ESRD) treated with dialysis, experience a high risk of all-cause and cardiovascular mortality. Peritoneal dialysis (PD), and haemodialysis (HD) are considered equally effective as initial dialysis modalities. However,as patient preference, centre experience and comorbidities affect the choice of modality, the prognostic effect of choice of initial dialysis modality needs to be further explored. Our aims were to utilize propensity score to correct for confounding variables when comparing all-cause and cardiovascular mortality in patients treated with PD and HD as initial dialysis modality. Methods: ESRD patients entering the Norwegian Renal Registry for the first time by initiating dialysis in the period from January 2005 to December 2012 were included. Time dependent propensity scores for starting PD were calculated to correct for confounding variables at the time of dialysis initiation. Propensity score adjusted Cox regression models were used to investigate for independent differences in all-cause and cardiovascular mortality between HD and PD. Cases were censored for shift in dialysis modality, renal transplantation or loss to follow-up. Results: Incident ESRD patients entering dialysis in the period counted 3555; mean age 65 ± 15 years, 67.7 % men. PD was the initial dialysis modality in 754 patients (21.2 %). There were regional differences in the use of PD and HD as initial modality ( p<0.001). Clinically, patients treated with PD were older ( p=0.001), had lower body mass index ( p<0.001), higher eGFR ( p=0.003) and higher haemoglobin and albumin levels (both p<0.001). PD patients had less established heart disease ( p=0.008), peripheral vascular disease ( p=0.002) and malignant disease ( p=0.031) and were more likely to be treated with erythropoiesis stimulating agents ( p=0.020). Furthermore, patients initiating PD were more likely to start dialysis in a planned manner ( p<0.001) and were considered more likely to be suited for future transplantation ( p=0.008). Some aetiologies of renal failure were more likely to be treated with a particular dialysis modality ( p<0.001). Median follow-up before death or censoring was 13 months (range 0-92) in HD patients, and 10 months (0-73) in PD patients. PD as initial dialysis modality was not independently associated with altered risk of all-cause and cardiovascular mortality compared to HD (HR 1.04, 95 % CI 0.86-1.25 and HR 1.10, 95 % CI 0.83-1.44 respectively). Dialysis modality was also neutral concerning 1-year all-cause and cardiovascular mortality (PD vs. HD: HR 0.94, 95% CI 0.71-1.25 and HR 0.84, 95% CI 0.54-1.29). Conclusions: Initial dialysis modality was not independently related to all-cause or cardiovascular mortality in Norwegian patients initiating renal replacement therapy from 2005 to 2012.

Yuji Sato 1 , Shouichi Fujimoto 2 , Tatsunori Toida 1 and Hideto Nakagawa 1 1 University of Miyazaki Hospital, Miyazaki, Japan, 2 University of Miyazaki, Miyazaki, Japan

Introduction and Aims: As NT-proBNP is a marker of volume overload and myocardial injury, it has been reported as a survival predictor for dialysis patients in terms of all-cause death and cerebrovascular death (CVD) in a relatively small number of patients. Conclusions: NT-proBNP is a strong survival predictor for all-cause death and CVD, and a modest but significant predictor for infectious disease death and tumor death.

Alexandra Tasmoc 1,2 , Ionut Nistor 2 , Mihaela Donciu 1,2 , Luminita Voroneanu 1,2 , Carmen Volovat 1 and Adrian Covic 2,1 1 University Hospital "Dr. C.I. Parhon", Iasi, Romania, 2 Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", Iasi, Romania Introduction and Aims: Pain and symptoms evaluation are increasingly perceived as important in patients`management in dialysis units and palliative care institutes. There is little experience on using the Memorial Symptom Assessment Scale Short-Form (MSAS-SF) in end-stage renal disease population. MSAS-SF is a useful tool that assesses not only the prevalence of symptoms, but also assesses the severity of symptoms experienced by patients. The objectives of this study were: i. to validate the MSAS-SF in a Romanian hemodialysis (HD) population, ii. to assess the prevalence and severity of physical and psychological symptoms of hemodialysis patients using the MSAS-SF, iii. to determine the quality of life of HD patients, including two summary scores: physical component (PCS) and psychological component (MCS). Methods: Seventy hemodialysis patients were recruted for assessing the internal reliability of MSAS-SF. A different group of 102 stable patients (41 males, 61 females, mean age 52.51 ± 12.02), who were treated with hemodialysis three times weekly completed questionnaires on prevalence and severity of symptoms and quality of life. To determine symptoms prevalence and severity for HD patients MSAS-SF was used, while for determing the quality of life, patients completed the Short Form Health Survey Questionnaire (SF-36). Cronbach`s alpha reliability test was performed to assess internal consistency of the MSAS-SF. Results: The Cronbach`s alpha reability score for the total number of items of the MSAS-SF was 0.838, while for the subscales of MSAS-SF the reability scores ranged from 0.648 to 0.749. This means that subscales ranged from acceptable to very good. The top three memorial symptoms experienced by hemodialysis patients were lack of energy, followed by pain, and worrying. The most frequently reported physical symptoms included lack of energy (69.6%), pain (68.6%), numbness/tingling in hands/ feet (64.7%), difficulty sleeping (63.7%), dry mouth (61.8%), dizziness (58.8%), problems with sexual interest or activity (52%). The most frequent psychological symptoms included worrying (65.7%), feeling sad (59.8%), feeling nervous (50%), feeling irritable (40.2%). The mean physical component summary (PCS -Quality of Life) score was 51.78 ± 19.21, and the mean mental component summary (MCS -Quality of Life) score was 61.38 ± 16.71. No statistical relationship between biochemical parameters and MSAS-SF and QoL scores was found. Conclusions: These results support the validity of the MSAS-SF in the assessment of patients undergoing hemodialysis. The major concerns in HD patients were the lack of energy, pain caused by symptoms and keep worrying about everything in their life. ) has been developed to estimate a 10-year absolute risk of major osteoporotic fracture among general population; however the evidence in CKD patients has been lacking and the association between the FRAX ® and mortality is unknown. We, therefore, conducted a hospital-based prospective cohort study to evaluate the predictive ability of the FRAX ® for mortality in hemodialysis patients. Methods: Two hundred and fifty-two patients who had been started initiate maintenance hemodialysis from April 2004 to December 2013, 171 men and 81 women, with a mean (± SD) age of 67 ± 14 years were studied. The endpoint was defined as all-cause death. The Cox proportional hazard model was used to calculate the hazard ratio (HR) and 95% CI. Results: During the mean (± SD) follow-up period of 3.4 ± 2.7 years, total 61 death were observed. The median (interquartile range) of the FRAX ® for major osteoporotic fracture were 6.9 (4.6 -12.0) % in men and 19.0 (7.6 -33.0) % in women. A significant interaction between the FRAX ® and gender was detected ( p interaction < 0.001); therefore, separate analyses were conducted for men and women. Cumulative survival at the point of 5 years after starting dialysis, in men with the FRAX ® levels above and below the median was 51.9 and 87.9 % and in women was 67.4 and 83.7 %, respectively ( Figure) . Overall, in men, the multivariate Cox regression analyses revealed that the log-transformed FRAX ® remained as an independent predictor for death after adjusting by confounding variables (Model 2: HR 3.03, 95% CI 1.37 to 6.70). In women, the FRAX ® was not associated with the endpoint (Table) . Conclusions: Among Japanese hemodialysis patients, the FRAX ® levels seem to be a useful procedure to predict for death in men but not in women. Introduction and Aims: The advances in intensive dialysis contributed to re-discuss the issue of pregnancy in dialysis patients. In spite of the renewed interest, and of the improved results, pregnancy is still exceptional on dialysis. Few data are available comparing pregnancy rates on dialysis and after kidney transplantation also with respect to the overall population. Aim of the study was to assess the incidence of live-born babies from mothers on chronic dialysis in Italy, in the new millennium, comparing the results with the overall population and with kidney transplant patients. Interestingly, about half of the mothers had no residual diuresis (and a long dialysis vintage) and one third had immunologic diseases, including SLE and vasculitis, thus suggesting that pregnancy is possible also after a long dialysis follow-up or with "difficult" diseases. Preterm delivery was the rule: 19/21 singletons with available data were preterm (33.3% were "early preterm", ie <34 gestational weeks). The prevalence of children below the 10th weight percentile (gestational age-adjusted) was high: 33.3%. Three babies died in the first months of life (including one twin). The surviving children had no clinical or developmental problem. The most common therapeutic adjustment was the switch to daily dialysis (and an increase in exchanges in peritoneal dialysis). As expected, comparing the data with 110 pregnancies recorded after kidney graft (about 60% of the Italian grafted population), birth weight was lower on dialysis (1200 vs 2500 g; p<0.01), and gestational age was also lower (30 vs 36 weeks, p<0.01). Incidence of live-born babies was inferred as 0.7-1.1 per 1000 female dialysis patients in childbearing age (age 20-45 years) and 5.5-8.3 per 1000 grafted patients of the same age groups. This figure corresponds to a live-birth rate in the Italian population of 72.5 per 1000 women aged 20-45 years.

Conclusions: Having a baby on dialysis is rare but not impossible; early mortality remains high. There is a "scale of probability" with an about 10 folds decrease of probability of a live-born baby from the overall population to transplantation and from transplantation to dialysis.

Introduction and Aims: Visceral adiposity index (VAI) is a newly-derived measure of visceral adiposity with well-validated predictive power of cardiovascular (CV) outcomes in general population. However, this predictability has not been investigated in hemodialysis (HD) patients and whether VAI is superior to waist circumference (WC) and waist-to-height ratio (WHtR) in prediction of CV outcomes and survival in HD patients remains unknown. Methods: We performed a prospective study and 464 prevalent hemodialysis patients were enrolled. The composite outcome was the occurrence of death and CV event during follow-up. Using multivariable Cox regression model, VAI, WC and WHtR were tested for the predictive power of composite outcome and all-cause mortality. Results: VAI, WC and WHtR positively correlated with each other. Patients with higher VAIs (tertile 3 v.s tertile 1, adjusted hazard ratio (HR), 1.65; 95% confidence interval (CI), 1.12 to 2.42; tertile 2 v.s tertile 1, adjusted HR, 1.52; 95%CI, 1.1 to2.18) had more composite outcomes. VAI had similar predictive power of composite and CV outcomes to WC and WHtR, but had superior predictive power of all-cause mortality to WC and WHtR analyzed by receiver operating characteristic curve. Conclusions: VAI is an optimal method to measure visceral adiposity for assessing long-term CV outcome and all-cause mortality in prevalent HD patients. VAI may provide superior predictive power of all-cause mortality to WC and WHtR.

Introduction and Aims: Optimal time to initiate dialysis for end stage renal disease patients is still a controversial question. Studies done recently challenged early initiation trend of dialysis. We conducted the study to evaluate the relationship between GFR and mortality in hemodialysis (HD) patients in Beijing.

Methods: A total of 5612 incident HD patients enrolled in the database from January 2007 to December 2012. eGFR was estimated by the CKD-EPI equation according to the creatinine at the start of dialysis. Patients were classified into five groups based on eGFR (Group 1: 0-2.5, Group 2: 2.5-5.0, Group 3: 5.0-7.5, Group 4: 7.5-10.0 and Group 5: above 10.0 ml/min/1.73m (2)). Kaplan-Meier and Cox regression analyses were performed to assess the association between eGFR and all-cause mortality. The Cox regression model included pre-dialysis eGFR, age, gender and primary renal disease. Results: The eGFR at dialysis initiation was 8.88±13.69 ml/min/1.73m(2). During the six years' follow-up, 17.18% patients died. The Cox regression model revealed increasing mortality risks was not only in the higher eGFR groups (Group 3 (HR=1.28, 95%CI=1.08-1.53), 4 (HR=1.39, 95%CI=1.13-1.71) and 5 (HR=2.29, 95% CI=1.90-2.76)), but also in Group 1 (HR=1.68, 95%CI=1.15-2.45), compared to Group 2 after adjusted for age, gender and primary renal disease (chronic glomerulonephritis, diabetic nephropathy, hypertensive nephropathy, chronic tubulointerstitial nephritis, polycystic kidney disease and others).

Conclusions: Initiation of dialysis at higher levels of eGFR was associated with increased mortality in HD patients in the long follow-up period. Meanwhile, too low eGFR (<2.5 ml/min/1.73m(2)) might also induce to higher mortality. The factors related need further studies.

Little is known about kidney function in volunteers recruited as healthy controls. Here we report kidney function in such individuals. Methods: We solicited the participation of healthy volunteers using posters and newspapers. Telephone callers underwent a structured 22 questions to explore their eligibility. Volunteers who passed the telephone interview underwent clinical assessment (height, weight, blood pressure) and measurement of serum creatinine, BUN, urinalysis) 1-4 weeks later. Estimated glomerular filtration rate (eGFR) was computed with the CKD-EPI equation. Albumin-creatinine ratio (ACR) was calculated as urine albumin/urine creatinine (mg/g). Systolic blood pressure (SBP) was recorded three consecutive times in a sitting position; subjects with average SBP > 140 mmHg were considered hypertensive.

Results: Based on the phone interview, almost 50% of 180 volunteers were excluded because of kidney, cardiac, or malignancy-related conditions. Ninety-one participants (age 57±10 years; 49 female) were eligible. Of these 18 participants were excluded, mostly because of absent blood and urine samples. Results obtained in the remaining 73 participants are shown in Table 1 . Age was significantly different between eGFR groups ( p = 0.001, 1-way ANOVA).

Our results indicate the presence of unrecognized kidney impairment in a notable fraction of normal healthy volunteers who identify themselves as healthy and who pass a telephone interview screening aimed at identifying and excluding non-healthy volunteers. Since decreased function of unknown cause is frequent in older people this should be considered in recruiting apparently healthy volunteers. Introduction and Aims: The purpose of this study is to evaluate health-related quality of life of patients undergoing high convective volume online hemodiafiltration, and contribute to current controversial discussions regarding online hemodiafiltration. Methods: In this study, end stage renal disease patients treated in an ambulatory healthcare centre, in which for 10 years all hemodialysis patients are treated by online hemodiafiltration, were offered to participate in an optional assessment of their health-related quality of life (no selection bias within the centre, total 200 patients). Assessment was performed with the Kidney Disease Quality of Life -Short Form. Based on publications of the Dialysis Outcomes and Practice Patterns Study, socioeconomic and clinical data of each patient were used to estimate expected health-related quality of life scores. These expected scores were subsequently compared to the actual scores as indicated by the patients ( paired t-test).

Results: 111 questionnaires returned (response rate 55%). The mean age of analyzed patients was 68 ± 13.8 years, 55.6% were male. Mean convective volume was 25.2 l ± 5.1 l (median 26.0 l). In several domains concerning health-related quality of life, patients undergoing online hemodiafiltration reported significantly higher scores than predicted by the model. These domains include physical component summary (P<0.001), physical functioning (P<0.001), pain (P=0.002), general health (P<0.001), social functioning (P=0.011), mental health (P=0.002), symptoms and problems (P=0.047), and cognitive functioning (P<0.001).

Conclusions: In contrast to other studies, these data suggest that health-related quality of life of end-stage renal disease patients benefits from online hemodiafiltration.

Though not a randomised controlled trial, this study might contribute to current discussions regarding online hemodiafiltration: The high convective volume in this patient group should be noted. It might explain discrepancies to results of other studies. However, these data result from only one centre, to exclude selection bias further research is needed. Institute of Nephrology Nams of Ukraine, Kyiv, Ukraine

Introduction and Aims: Candidiasis is a common opportunistic infection in immunocompromised patients. Infection is a major cause of morbidity and mortality in patients with end stage renal failure (ESRF). ESRF patients on haemodialysis (HD) have a high frequency of nutritional, immunological, and psychological disorders as well disorders from invasive procedures and antimicrobial treatments, which are known to contribute to the presence of a higher number of yeast colonies. The aim was to study the localization and prevalence of fungal colonization with subsequent evaluation of medium term outcomes in HD patients. Conclusions: JSDT recommended that the dialysis conditions should be determined to achieve a pre-dialysis serum β2M level at the maximum intervals < 30 mg/L. In this study, less than 30mg/L of pre-dialysis serum β2M levels is lower mortality in dialysis patients independent of age, haemodialysis duration, the presence of diabetes, pre-dialysis serum, albumin, and blood urea nitrogen, from the point of view, the guidelines are appropriate. Therefore, we may have to design the dialysis conditions to achieve effective removal of β2M. Introduction and Aims: Hemodialysis patients lack normal homeostatic mechanisms to regulate body water volume and osmolality. However they too seem to have its own individual's osmolar set point, and being dialysed against a positive sodium gradient might be associated with increased interdialytic weight gain and blood pressure and therefore an individually sodium prescription approach may be beneficial. Methods: We conducted a cross-sectional study at a hospital based hemodialysis unit, SP631 during a period of 3 months, comprising 40 clinically stable patients on hemodialysis. A descriptive analysis of each patient sodium dialysis prescription and analytical/ clinical data was assessed for statistical analysis.

Results: From the analysis of both the prescription and clinical data of the patients comprised in the study we found that the dialysate sodium prescription ranged from 138-140mEq/L (median of 140 mEq/L) while the mean pre-HD serum sodium was 134,6 ±2,27mEq/L. This resulted in a mean sodium gradient of 5,0 ±2,3mEq/L with the majority of patients (n=39, 97,5%) being dialysed against a positive sodium gradient. We found a direct correlation between sodium gradient and IDWG (ρ=0,317, p<.05), sodium gradient and percent IDWG (%IDWG) (ρ=0,398, p<.05) and sodium gradient and number of intradialytic hypotensive episodes (ρ=0,540, p<.01). After adjustment for confounders (age, dialysis vintage, dry weight), the sodium gradient was independently associated with %IDWG ( p<.05). We found no significant associations either between sodium gradient and blood pressure control, number of antihypertensive agents, hospitalizations, medical complications or death.

Conclusions: Despite the small sample, it was possible to find statistical significance between the sodium gradient and IDWG, %IDWG and intradialytic hypotensive episodes suggesting the importance of individual hemodialysis sodium prescription in order to look for alignment between the dialysate sodium with the serum sodium concentration.

Hannah Currie 1 and J Baharani 1 1 Heart of England NHS Foundation Trust, Birmingham, United Kingdom

Introduction and Aims: End-stage renal disease (ESRD) is associated with cognitive impairment (CI) and it is estimated that as many as 70% of haemodialysis(HD) patients aged 75 years or over have moderate to severe CI. The pathophysiology remains unclear but its effects undeniable with the paradigm shift in more elderly patients than ever needing HD. A single study conducted amongst 28 haemodialysis patients aged 55 years or older found that cognitive function was significantly lower during a dialysis session compared to shortly before or the following day after dialysis.

The aim of this pilot study was to further assess the effect of a single haemodialysis session on the cognitive function of established and stable haemodialysis patients. Methods: Patients aged 60 or above established on HD for 3 months with no prior documentation of memory impairment were included. 30 patients were randomly selected from our local haemodialysis cohort and were invited to participate. Prior to a dialysis session they completed a MMSE and if scored >24 were assessed further using the Montreal Cognitive Assessment tool (MoCA). The MoCA is a one-page 30-point test administered in approximately 10 minutes and has 3 versions enabling its re-use in a short space of time. Patients completed the MoCA-1 at baseline prior to commencing HD, MoCA-2 at 1 hour into dialysis and MoCA-3 within 1 hour of completing the session.

Results: All 30 patients agreed to participate. 1 was excluded for scoring ≤24 on their MMSE. 29 patients with an M: F ratio of 3:1 and a mean age of 73 years (range 64 -84) completed the cognitive tests. 97% were Caucasian. Mean duration on dialysis was 37.2 months (6 -88 months). 13.8% were diabetic and 97% were dialysed via a fistula. Mean Karnofsky score was 70% and only 15% were in the low co-morbidity group. The mean baseline MMSE was 27.6 (25 -30) and MOCA-1 was 20.9 (14 -27). Mean 1 hour MOCA-2 was 20.1 (13 -25) and mean recovery MOCA-3 was 19.6 (12 -25). Baseline MoCA scoring in this cohort revealed that 75% had mild to moderate CI not evident on MMSE. There was evidence that CI worsened during dialysis in 55% and did not fully reverse or fell further in 65% of the cohort following completion of dialysis. Conclusions: Our pilot shows that CI is present in three quarters of our patients over the age of 60 years who are receiving long term HD. Despite the presence of CI these patients had reasonable functional scoring despite moderate to high co-morbidity. CI worsened during HD in half the group and did not fully recover or worsened further at the end of the session. This raises implications in the short term for those travelling home alone or to an empty home after HD. In the long term, there are wider implications with sharing the diagnosis of CI with patients which goes hand in hand with future planning of care, prognosis and outlook. has created global havoc because of its high case fatality rate. The natural history of this infection in hemodialysis (HD) patient has not been studied well. To the best of our knowledge this is the largest single center case series reporting of MERS-CoV infected hemodialysis patient population. These patients were admitted in prince sultan military medical city (PSMCC), nephrology ward and their outcomes are reported in this study. Methods: Four consecutive patients were included in this reporting. All these patients were isolated and diagnosis was made by PCR. Their Clinical presentation, total hospital stay, ventilation requirement and mortality rate was studied. Three serial blood, sputum and urine cultures were done to exclude any possibility of bacterial or fungal sepsis. Results: Three patients were male, the median age being 51.5 years. All of them were diabetic and hypertensive. Out of 4 infected patients 3 were recently started on HD through permanent catheter with a mean average premorbid duration on dialysis for 64 days. The fourth patient was on dialysis through fistula for 993 days before infection. The average hospital stay was 43 days. 75 % presented with pneumonia by clinical and radiological criteria. 100% of them presented with lymphopenia and fever. None of them had associated permanent catheter infection. One of them received intravenous immunoglobulin and was discharged home after 6 weeks and did not require ventilator support during hospital stay. 50% of them needed mechanical ventilator and eventually died due to multiple organ failure. One patient, who had flue like symptoms recovered fully without any intervention but was kept in hospital for 6 weeks until PCR became negative for MERS-CoV.

Conclusions: MERS-CoV infection in HD patients has prolonged hospital stay and is associated with higher mortality, thus contrasting with the non HD population. Results: Participants reported moderate burden severity according to ZBI classifications at both baseline and followup assessments, although ANOVA comparisons indicated a statistically significant increase in caregiver burden ( p = 0+) at followup. Participants also reported poorer QOL outcomes in terms of psychological health ( p = 0.011) at followup. Additionally, overall QOL levels were found to be worse relative to general population norms in all domains at both baseline and followup assessments. Symptoms of anxiety and depression measured higher in caregivers reaching threshold scores for moderate to severe burden as per ZBI classifications. High burden caregivers are also found to be providing care for older patients (p = 0.04).

Conclusions: Overall, the results suggest that caregivers of PD patients experience increased burden over time and are at risk for anxiety, depression and poor psychological health. PD regimes offer flexibility and autonomy for patients, but may result in increasing caregiver burden over time due to factors such as the requirement to assist in managing multiple, technical aspects of PD exchange. Additionally, an inverse relationship between patient age and caregiver QOL is documented, suggesting the need to further understand the various clinical needs of different age groups in PD patients that may translate into different burdens on caregivers. The study results raises questions on ways to promote wellness in the context of the PD family unit and to address psychosocial needs in the PD caregiver population. Methods: 312 individuals were included in the study and the following pre-and postoperative data were analyzed -demography, cardiovascular and respiratory comorbidities, dialysis time, diuresis, BP variations, APACHE II score, preoperative EMG to assess the degree of autonomic neuropathy, complexity of surgical procedure, type of anesthesia, levels of CRP, hemoglobin, albumin, and clinical status at discharge. Patients with no surgical related-infections, improved clinical status and values of albumin > 4g/dL, hemoglobin > 8g/dL, and CRP < 1mg/dL represented group A; the rest of subjects formed group B. We analyzed the data using Chi-Square test and compared the findings of the 2 groups calculating the relative risk and confidence intervals ( p = 0.05). Results: The percentage of patients receiving spinal anesthesia was significantly higher (48.75%) in group B versus group A (25%), with increased poor outcome and prevalence of postoperative hypotension events comparing to general anesthesia (69.23%, p = 0.0479). Additionally, elevated preoperative degrees of autonomic neuropathy strongly correlated with hypotensive episodes after spinal anesthesia (Chi-Square = 35.412, df = 2; p < 0.001).

Conclusions: Chronic dialyzed patients receiving spinal anesthesia presented more often unfavorable prognosis, hypotensive events and risk of sympathetic blockade. Our study highlighted that general anesthesia offered a better global control of different bioumoral variables (e.g.: hemoglobin, albumin), especially since the use of new volatile agents. Furthermore, preoperative EMG findings may be useful in predicting the risk of hypotension episodes after spinal anesthesia in chronic dialyzed individuals. Further extensive clinical trials are needed to support our results for choosing the right anesthesia type and performing preoperative EMG by routine in this group of population. Stepwise multivariate logistic regression with backward selection was performed.

Results: The mean of EQ-5D index score was 0.702 (SD=0.199). The variables showed significant association with EQ-5D were depression (r=-0.381, p<0.001), anxiety (r=-0.346, p<0.001), support from friends (r=0.370, p<0.001), cognitive function (r=0.227, p=0.015), insomnia (r=-0.181, p=0.043), duration of HD (r=-0.207, p=0.025), albumin (r=0.175, p=0.048) and BMI (r=0.188, p=0.037). Multiple regression showed that anxiety ( p<0.001), cognitive function ( p=0.049) and BMI ( p=0.026) were independent predictors of impaired quality of life.

Conclusions: This study explored the determinants of high susceptibility to the impaired quality of life in HD patients. We found that the impaired quality of life is associated with the anxiety, cognitive function and BMI. We should consider psychosocial factors as well as clinical ones for improving the quality of life in HD patients.

Leszek Domanski 1 , Karolina Kłoda 1 , Tomasz Prystacki 1 , Krzysztof Safranow 1 , Violetta Dziedziejko 1 and Kazimierz Ciechanowski 1 1 Pomeranian Medical University In Szczecin, Szczecin, Poland

Introduction and Aims: Hemodialysis (HD) remains the main method of end stage renal disease (ESRD) therapy in Poland. Well-being of patients undergoing dialysis can be measured through assessment of the dialysis effectiveness and biochemical blood parameters evaluation. Dialysis index estimated with use of single pool Kt/V or urea reduction ratio (URR), are standard measures used to quantify HD treatment adequacy. The aim of this study was the analysis of 9 dialysis centers (DCs) modern management association with patients' health status evaluated through HD effectiveness, anemia severity, iron metabolism, blood pressure control, Ca and P concentrations.

Methods: A retrospective review (2000-2012) of 16439 HD patients medical records was performed. All these individuals originated from 9 DCs, which began to be managed efficiently at different time points. We analyzed the HD adequacy expressed with spKt/V and URR. Moreover, the current duration of HD (hours per week) and total time of HD treatment (months) was also recorded. Patients' anemia severity and iron (Fe) metabolism parameters were assessed. The serum concentration of Ca, P, and Ca x P product were evaluated. Finally, subjects' systolic (SBP) and diastolic blood pressure (DBP) were noted down and mean arterial pressure (MAP) was estimated.

Results: The average HD duration per week and total time of HD treatment were significantly longer in managed time period ( p<0.00001 and p<0.00001 respectively). The effectiveness of dialysis measured with URR and spKt/V was significantly higher in managed DCs ( p<0.00001 and p<0.00001 respectively). The anemia severity and iron metabolism parameters -Hb, ferritin, administration of ESA per week and per kg body weight, and administration of Fe per week differed significantly between unmanaged and managed time period ( p<0.00001, p=0.0009, p<0.00001, p<0.00001and p<0.00001 respectively). The P concentrations and Ca x P product were significantly lower in managed time period ( p<0.00001 and p<0.00001 respectively). DBP and MAP were significantly lower in managed time period ( p=0.02 and p=0.009 respectively). Conclusions: Results from our study confirm that modern management of dialysis center improves patients' health status evaluated through HD effectiveness, anemia severity, iron metabolism, blood pressure control, Ca and P concentrations. Tallinn University of Technology, Tallinn, Estonia, 2 Linköping University, Linköping, Sweden, 3 North Estonian Medical Centre, Tallinn, Estonia

Introduction and Aims: It has been reported that the mean life expectancy of hemodialysis patient is less than 3 years [1] . Therefore, markers and methods for patient outcome estimation are highly longed for. Widely used small molecular weight markers for estimating kidney function and dialysis adequacy are creatinine and urea [2] . Using urea nitrogen appearance in serum/urine/dialysate allows to calculate of PNA ( protein nitrogen appearance) and/or nPNA (normalized PNA) for estimation of nutritional status in dialysis patients [3] . Several studies suggest that a high level of uric acid (UA) may play an important role in the development of hypertension, renal disease and cardiovascular events [4] [5] [6] [7] [8] . In some regions, UA is considered as an essential molecule to monitor in dialysis patients [9] . The purpose of this study was to examine if simultaneous monitoring of two small molecule uremic markers, urea and UA, could be related to 3-year survival of dialysis patients. 

Cristiana David 1 , Ileana Peride 1 , Daniela Radulescu 1 , Andrei Niculae 1

Semin Dialysis, 2005.3. Fouque

Alessandro Palermo 1 , Paola Cusimano 1 and Grazia Locascio 1

Methods: Among the patients followed in our Dialysis Centre, 41 elderly (over 65 years) patients received the questionnaires. First, patients had to fill in the ultra-brief Patient Health Questionnaire (PHQ) with only 2 questions (PHQ-2). A score of 3 or greater prompted the administration of the brief version of the Geriatric Depression Scale (GDS) with 5 instead of 15 questions (GDS-5) as a confirmation of depression symptoms, and of the full PHQ-9 (9 questions), used as a grading instrument. A GDS-5 score of 2 or greater was considered as positive for depression screening. PHQ-9 scores of 5, 10, 15 and 20 represented cutpoints for mild, moderate, moderately severe and severe depression

Conclusions: In our hemodialysis population depressive symptoms were highly prevalent, consistently to previous literature data, which show prevalence of 24-58% in dialysis patients, higher than general population and comparable to cancer patients. Further, depressive symptoms were relevant (moderate or worse) in almost 80% of patients, likely influencing health and quality of life of patients and of their care givers

Shigeru Otsubo 1 , Ken Tsuchiya 2 , Takashi Akiba 2 and Kosaku Nitta 2

Methods: A total of 67 patients receiving maintenance hemodialysis at Sangenjaya Hospital were enrolled in this study. Clinical data, including age, gender, duration of hemodialysis therapy and cause of end-stage kidney disease, were collected. The clinical follow-up data were obtained from the hospital records. A peripheral blood sample was obtained before hemodialysis on a Monday or a Tuesday, and standard biological data were measured. RLS was diagnosed according to the four diagnostic criteria established by the International RLS Study Group. The clinical endpoints were defined as death from any cause. Cox proportional hazards model for the predictor of survival was examined. We divided patients according to the presence or absent of RLS and compared the survival rate between the groups. The survival curves were estimated using the Kaplan-Meier method followed by a log-rank test. Results: RLS affected 14.9 % of the study population. The mean observation period was 2.8 ± 0.8 years. During the follow-up period, 15 deaths were recorded. In the univariate regression analysis, the hazard ratio (HR) of patients with RLS was 2.16 (95% CI, 1.25 -3.61, P=0.008). A multivariate Cox analysis which include age, albumin, creatinine and presence of diabetic nephropathy identified RLS as an independent predictor of mortality (HR 2.19 (95% CI 1.21 -3.93), P=0.011). The survival curves showed a statistically significant difference between patients with and without RLS (P=0.010). Patient survival rate at 2 years was 70.0 % in the patients with RLS group and 91.0 % in the patients without RLS. Conclusions: RLS was a risk factor for mortality and acted independently of other risk factors

There was significant difference between HD (65.6% within 1-5 years and 3.4% over 15 years) and DN groups (73.5% within 1-5 years and no patients over 15 years) in dialysis vintage (P<0.001). In terms of hemoglobin (Hb) and hematocrit (Hct) level, there was no significant difference of Hb between HD and DN (P>0.05) groups, but significant difference of Hct (30.5% versus 31.5%, P<0.01). The average erythropoietin (EPO) dosages were similar in HD and DN groups (8185 versus 8263 IU per week, P>0.05). There was no significant difference of URR, KT/V, BMI, iPTH, serum total calcium, total protein, albumin (P>0.05), but significant difference of serum phosphate (2.0 versus 1.7 mmol/L, P<0.001) in DN and HD groups. There was significant difference in vascular access between DN and HD groups (P<0.001). Although over 80% patients in both groups use arteriovenous fistulas (AV fistulas), more patients in HD group were using temporary venous catheter than permanent venous catheter

This may be because the progression to DN usually takes 10-20 years after diabetes, patients are usually older and more fragile, with more complications and less life expectancy. Also, since maintenance HD is necessary for most DN patients on HD, permanent venous catheter is preferred than temporary venous catheter. Both DN on HD patients and all HD patients had anemia

The study was performed after approval of the protocol by the Regional Ethical Review Board, Linköping, Sweden. 30 dialysis patients (26 male and 4 female, mean age 73±11 years) were followed. Logistic (logit) regression analysis was used for creating models for 3 years survival probability estimation. Since patient's baseline creatinine level turned out to be an insignificant parameter for the model ( p>0.05), baseline serum urea and UA levels were selected for independent parameters. Three models were created: two single molecules based and one combined model. The performance of the models was evaluated by Receiver Operating Characteristic (ROC) curve. Results: During the follow-up 21 patients died and 9 survived. Figure 1 shows that using combined logistic regression models could lead to more accurate results, compared to a single molecule model. It suggests that survival probability may be determined by a set of causal factors. Figure 1 . ROC curves of the created models for estimating dialysis patient's 3 year survival. Models used baseline urea, UA or combination of both for prediction. Conclusions: The main limitation of this study was a small study group. However, by our knowledge this kind of parameter combining approach is unique and has a potential to improve the quality of dialysis, and hopefully also life expectancy of dialysis patients. The future goal is to test created models in a larger independent validation cohort and make adjustments if needed.